Umoja Biopharma and IASO Biotherapeutics Announce Research Collaboration to Bring Off-the-Shelf Therapies to Patients with Hematological Malignancies

Umoja Biopharma, Inc. and IASO Biotherapeutics announced that they have entered into a research agreement to evaluate Umoja’s iCIL platform with IASO’s best-in-class CARs.